Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C8H16O4 |
| Molecular Weight | 176.2102 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](O)CCOC(=O)C[C@@H](C)O
InChI
InChIKey=AOWPVIWVMWUSBD-RNFRBKRXSA-N
InChI=1S/C8H16O4/c1-6(9)3-4-12-8(11)5-7(2)10/h6-7,9-10H,3-5H2,1-2H3/t6-,7-/m1/s1
(R)-3'-hydroxybutyl (R)-3'-hydroxybutyrate or D-β-hydroxybutyrate ester is a is an effective and palatable precursor to the ketone body. Ketone bodies are the most energy-efficient fuel and yield more ATP per mole of substrate than pyruvate and increase the free energy released from ATP hydrolysis. Ketone diet containing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate, improved physical performance and cognitive function in rats, and its energy-sparing properties suggest that it may help to treat a range of human conditions with metabolic abnormalities. It may be used to treat a condition which is caused by, exacerbated by or associated with elevated plasma levels of free fatty acids in a human or animal subject, for instance a condition where weight loss or weight gain is implicated, or to promote alertness or improve cognitive function, or to treat, prevent or reduce the effects of, neurodegeneration, free radical toxicity, hypoxic conditions or hyperglycaemia. It has been approved by the FDA as “Generally Regarded as Safe (GRAS)”.
CNS Activity
Approval Year
Sample Use Guides
(R)-3-hydroxybutyl (R)-3-hydroxybutyrate, a ketone monoester, was administered at 140, 357, and 714 mg/kg body weight, three times daily, over 5 days (equivalent to 0.42, 1.07, and 2.14 g/kg/d). The ketone ester was generally well-tolerated, although some gastrointestinal effects were reported, when large volumes of milk-based drink were consumed, at the highest ketone monoester dose. Together, these results suggest ingestion of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate is a safe and simple method to elevate blood ketone levels, compared with the inconvenience of preparing and consuming a ketogenic diet.
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
X587FW0372
Created by
admin on Sat Dec 16 09:58:08 GMT 2023 , Edited by admin on Sat Dec 16 09:58:08 GMT 2023
|
PRIMARY | |||
|
DTXSID20660064
Created by
admin on Sat Dec 16 09:58:08 GMT 2023 , Edited by admin on Sat Dec 16 09:58:08 GMT 2023
|
PRIMARY | |||
|
1208313-97-6
Created by
admin on Sat Dec 16 09:58:08 GMT 2023 , Edited by admin on Sat Dec 16 09:58:08 GMT 2023
|
PRIMARY | |||
|
44631890
Created by
admin on Sat Dec 16 09:58:08 GMT 2023 , Edited by admin on Sat Dec 16 09:58:08 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
